Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindström, J.
Right arrow Articles by Tuomilehto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindström, J.
Right arrow Articles by Tuomilehto, J.
J Am Soc Nephrol 14:S108-S113, 2003
© 2003 American Society of Nephrology


Supplement Article

Prevention of Diabetes Mellitus in Subjects with Impaired Glucose Tolerance in the Finnish Diabetes Prevention Study: Results From a Randomized Clinical Trial

Jaana Lindström*, Johan G. Eriksson*, Timo T. Valle*, Sirkka Aunola{dagger}, Zygimantas Cepaitis*, Martti Hakumäki{ddagger}, Helena Hämäläinen{dagger}, Pirjo Ilanne-Parikka§, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso**, Anne Louheranta{ddagger}, Marjo Mannelin**, Vesa Martikkala*, Vladislav Moltchanov**, Merja Rastas{dagger}, Virpi Salminen{dagger},{dagger}, Jouko Sundvall{ddagger}{ddagger}, Matti Uusitupa{ddagger} and Jaakko Tuomilehto*,§§

*National Public Health Institute, Department of Epidemiology and Health Promotion, Diabetes and Genetic Epidemiology Unit, Helsinki; {dagger}Social Insurance Institution, Research Department, Turku; {ddagger}University of Kuopio, Department of Clinical Nutrition, Kuopio; §Finnish Diabetes Association, The Diabetes Centre, Tampere; University of Oulu, Department of Public Health Science and General Practice, Oulu; **Oulu Deaconess Institute, Department of Sports Medicine, Oulu; {dagger}{dagger}Institute of Nursing and Health Care, Tampere; {ddagger}{ddagger}National Public Health Institute, Department of Health and Functional Capacity, Helsinki; and §§University of Helsinki, Department of Public Health, Helsinki, Finland.

Correspondence to Jaakko Tuomilehto, National Public Health Institute, Mannerheimintie 166, FIN-00300 Helsinki, Finland. Phone: 358-9-4744-8635; Fax: 358-9-4744-8338;

ABSTRACT. Type 2 diabetes mellitus is increasing worldwide largely as a result from increasing obesity and sedentary lifestyle. The Finnish Diabetes Prevention Study (DPS) is the first individually randomized controlled clinical trial to test the feasibility and efficacy of lifestyle modification in high-risk subjects. We randomly assigned 522 (172 men, 350 women) middle-aged (mean age 55 yr), overweight (mean body mass index 31 kg/m2) subjects with impaired glucose tolerance either to the lifestyle intervention or control group. Each subject in the intervention group received individualized counseling aimed at reducing weight and intake of total and saturated fat, and increasing intake of fiber and physical activity. An oral glucose tolerance test was performed annually to detect incident cases of diabetes and to measure changes in metabolic parameters. The mean (± SD) weight reduction from baseline to year 1 and to year 2, respectively, was 4.2 ± 5.1 kg and 3.5 ± 5.5 in the intervention group and 0.8 ± 3.7 kg and 0.8 ± 4.4 in the control group (P < 0.001 between the groups). At the time of first analysis of the outcome data the mean duration of follow-up was 3.2 yr. The risk of diabetes was reduced by 58% (P < 0.001) in the intervention group compared with the control group. The reduction in the incidence of diabetes was directly associated with number and magnitude of lifestyle changes made. In conclusion, the DPS is the first controlled trial demonstrating that type 2 diabetes can be prevented by changes in lifestyle in high-risk subjects. E-mail: jaakko.tuomilehto@ktl.fi




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu
Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, June 3, 2008; 148(11): 855 - 868.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Due, T. M Larsen, K. Hermansen, S. Stender, J. J Holst, S. Toubro, T. Martinussen, and A. Astrup
Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
Occup Med (Lond)Home page
C. Oberlinner, S. M. Neumann, M. G. Ott, and A. Zober
Screening for pre-diabetes and diabetes in the workplace
Occup. Med., January 1, 2008; 58(1): 41 - 45.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. T. Fung, M. McCullough, R. M. van Dam, and F. B. Hu
A Prospective Study of Overall Diet Quality and Risk of Type 2 Diabetes in Women
Diabetes Care, July 1, 2007; 30(7): 1753 - 1757.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. K. Chandie Shaw, S. P. Berger, M. Mallat, M. Frolich, F. W. Dekker, and T. J. Rabelink
Central Obesity Is an Independent Risk Factor for Albuminuria in Nondiabetic South Asian Subjects
Diabetes Care, July 1, 2007; 30(7): 1840 - 1844.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. A. Arky
"Doctor, Is My Sugar Normal?"
N. Engl. J. Med., October 6, 2005; 353(14): 1511 - 1513.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP